Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Biopharma
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Northern Arizona Healthcare (NAH) Partners with InsightRX on the First Commercial Precision Dosing Model For Heparin
Resources
Thought Leadership
Sep 11, 2024
Choosing the right model for your patient: An introduction to InsightRX Gemini
Thought Leadership
Sep 10, 2024
Streamlining Patient Care with EHR Integration
Thought Leadership
Jun 28, 2024
AUC Monitoring for Vancomycin: Comparing Estimation Methods
White Papers
Jun 21, 2024
InsightRX White Paper: Implementation Best Practices
Thought Leadership
Jun 13, 2024
Recognizing the value of therapeutic drug monitoring for beta-lactam antibiotics
White Papers
May 29, 2024
Case Study: Pre-/Post-Implementation; Can Bayesian MIPD enhance target attainment and clinical outcomes for patients receiving vancomycin?
Product Innovation
May 28, 2024
Introducing Apollo Gold: Enhancing Data-Driven Insights and Real-Time Recommendations
Scientific Publications
May 21, 2024
Developing Parametric and Nonparametric Models for Model-Informed Precision Dosing: A Quality Improvement Effort in Vancomycin for Patients With Obesity
Thought Leadership
Feb 27, 2024
Artificial Intelligence Drives Industry Response to Project Optimus
1
2
3
4
5
